These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31265639)

  • 1. Erratum: Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature: Erratum.
    Medicine (Baltimore); 2016 Sep; 95(36):e29d2. PubMed ID: 31265639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.
    El Ghorayeb N; Rondeau G; Latour M; Cohade C; Olney H; Lacroix A; Perrotte P; Sabourin A; Mazzuco TL; Bourdeau I
    Medicine (Baltimore); 2016 Mar; 95(13):e3180. PubMed ID: 27043680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers.
    Tőke J; Jakab Z; Stark J; Huszty G; Reismann P; Tóth M
    Front Oncol; 2021; 11():680853. PubMed ID: 34046364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug.
    Reidy-Lagunes DL; Lung B; Untch BR; Raj N; Hrabovsky A; Kelly C; Gerst S; Katz S; Kampel L; Chou J; Gopalan A; Saltz LB
    Oncologist; 2017 Sep; 22(9):1102-1106. PubMed ID: 28559412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma.
    Megerle F; Herrmann W; Schloetelburg W; Ronchi CL; Pulzer A; Quinkler M; Beuschlein F; Hahner S; Kroiss M; Fassnacht M;
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1686-1695. PubMed ID: 29452402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane.
    Ilias I; Alevizaki M; Philippou G; Anastasiou E; Souvatzoglou A
    J Endocrinol Invest; 2001; 24(7):532-5. PubMed ID: 11508789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: The malignant transformation of retrorectal cystic hamartomas with blood irregular antibodies positive: A case report: Erratum Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review: Erratum.
    Medicine (Baltimore); 2016 Dec; 95(49):e5672. PubMed ID: 31265672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A CASE REPORT: A PATIENT WITH METASTATIC ADRENOCORTICAL CARCINOMA EXCLUSIVELY TREATED WITH MITOTANE WITH LONG-TERM FOLLOW-UP].
    Yamashita D; Hanai T; Onuki T; Suzuki K; Nakayama T
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):12-17. PubMed ID: 31956212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Embolism as an Initial Presentation of Adrenocortical Carcinoma.
    Aung SY; Parente P; McKendrick J
    World J Oncol; 2014 Jun; 5(3):149-152. PubMed ID: 29147395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma.
    Seki M; Nomura K; Hirohara D; Kanazawa M; Sawada T; Takasaki K; Demura H
    Endocr Relat Cancer; 1999 Dec; 6(4):529-33. PubMed ID: 10730906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results of the use of mitotane for adrenocortical carcinoma.
    Kasperlik-Zaluska AA
    Braz J Med Biol Res; 2000 Oct; 33(10):1191-6. PubMed ID: 11004719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.
    Vezzosi D; Do Cao C; Hescot S; Bertherat J; Haissaguerre M; Bongard V; Drui D; De La Fouchardière C; Illouz F; Borson-Chazot F; Djobo B; Berdelou A; Tabarin A; Schlumberger M; Briet C; Caron P; Leboulleux S; Libe R; Baudin E;
    Horm Cancer; 2018 Feb; 9(1):62-69. PubMed ID: 29071575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma.
    Malandrino P; Al Ghuzlan A; Castaing M; Young J; Caillou B; Travagli JP; Elias D; de Baere T; Dromain C; Paci A; Chanson P; Schlumberger M; Leboulleux S; Baudin E
    Endocr Relat Cancer; 2010 Sep; 17(3):797-807. PubMed ID: 20592067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma.
    De León DD; Lange BJ; Walterhouse D; Moshang T
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4452-6. PubMed ID: 12364417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A CARE-Compliant Article: Erratum.
    Medicine (Baltimore); 2016 Aug; 95(34):e504a. PubMed ID: 31265630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.